Fonte: Lancet Neurology. Unidades: FM, EACH
Assuntos: TOXICINAS, DOR, ESTUDOS RANDOMIZADOS, NERVOS PERIFÉRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ATTAL, Nadine et al. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurology, v. 15, n. 6, p. 566-565, 2016Tradução . . Disponível em: https://doi.org/10.1016/S1474-4422(16)00017-X. Acesso em: 20 jul. 2024.APA
Attal, N., Andrade, D. C. de, Adam, F., Ranoux, D., Teixeira, M. J., Galhardoni, R., et al. (2016). Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurology, 15( 6), 566-565. doi:10.1016/S1474-4422(16)00017-XNLM
Attal N, Andrade DC de, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, Raicher I, Üçeyler N, Sommer C, Bouhassira D. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial [Internet]. Lancet Neurology. 2016 ; 15( 6): 566-565.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1016/S1474-4422(16)00017-XVancouver
Attal N, Andrade DC de, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, Raicher I, Üçeyler N, Sommer C, Bouhassira D. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial [Internet]. Lancet Neurology. 2016 ; 15( 6): 566-565.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1016/S1474-4422(16)00017-X
